Breville stock upgraded to Buy at UBS on global coffee machine growth

UBS upgraded Breville Group (ASX:BRG) to Buy from Neutral, increasing its price target to AUD35.50, based on analysis indicating the company could more than double global coffee machine sales over the next decade through continued core market strength and expansion into new Asian markets, particularly China. Despite a recent 20% stock decline attributed to short-term US tariff risks, UBS believes the market is overlooking Breville's consistent market share gains and robust long-term growth potential, projecting significantly higher FY35 net profit after tax and a potential valuation of AUD46 per share.

Analysis

UBS has upgraded Breville Group Ltd. (ASX:BRG) to Buy from Neutral, raising its price target to AUD35.50 from AUD33.10. The upgrade is underpinned by a robust long-term growth forecast, with UBS analysis indicating Breville could more than double its global coffee machine sales within the next decade. This thesis is supported by UBS Evidence Lab data pointing to sustained growth in core markets and significant expansion opportunities in new Asian markets, especially China, where Breville has demonstrated a consistent ability to capture market share. The bank's positive outlook contrasts with the stock's recent performance, which has seen an approximate 20% decline since February 2025. UBS attributes this weakness to short-term earnings risks associated with US tariffs, suggesting the market is overlooking the company's long-term value. In an upside scenario, UBS projects a potential 30% increase in Breville's FY35 net profit after tax, which could justify a valuation of around AUD46 per share.

Key Decisions for Investors

• Given the disconnect between the recent 20% stock decline and UBS's bullish long-term forecast, investors may view the current share price as a strategic entry point, capitalizing on the market's focus on short-term tariff risks.
• The execution of Breville's expansion into new Asian markets, particularly China, should be closely monitored as it represents a critical component of the projected long-term growth and the core rationale for the upgrade.
• Investors should weigh the significant long-term upside potential, highlighted by UBS's AUD46 per share upside valuation, against the near-term volatility and earnings pressure stemming from US tariffs.